TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2018

Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study.

Kensei Yamaguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.